—
C+
C+ The full Closelook — membership. Open the C+ overview

IQVIA Holdings Inc (IQV) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — IQVIA Holdings Inc

IQV in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
IQVIA supplies clinical trial services, commercial data and healthcare intelligence to life sciences and healthcare companies worldwide. It runs three segments: Technology & Analytics Solutions for cloud-based data and real-world evidence tools, Research & Development Solutions for running and supporting clinical trials and laboratory work, and Contract Sales & Medical Solutions for patient and provider engagement on behalf of clients. Its customers are pharmaceutical, biotechnology, device, diagnostic and consumer-health companies. It is headquartered in Durham, United States.
Where it sits in the stack
IQVIA holds no seat in Rubin, our index for the AI build-out. It sits in our universe's healthcare sleeve, under diagnostics and research, as a services and data provider that pharmaceutical and biotech companies use to run trials and read commercial markets.
Who it is priced against
The diary has not built a peer group for IQVIA. The name the market most often compares it with is ICON plc, another contract research organisation offering similar clinical-trial and laboratory services.
Why Closelook tracks it
IQVIA carries no Closelook score and no Rubin seat. The only index tag the diary holds for it is a place in the S&P 500.
What the diary watches
The diary watches whether pharmaceutical clients keep outsourcing clinical trial and commercial-data work at the same pace, since that flow moves the balance across IQVIA's three segments.

IQVIA Holdings Inc (IQV) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for IQV, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: price target by Morgan Stanley, 2026-09-17

The Street on this name

Analyst actions and the latest print for IQV from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target Morgan Stanley — target 270 from 240 Target raised to $270 from $240 (+0.4% to spot) 2026-09-17

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is IQVIA Holdings Inc (IQV)?

IQVIA Holdings Inc trades as IQV on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is IQV in a Closelook index?

Not currently — IQVIA Holdings Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does IQV trade against its moving averages?

Uptrend stack intact: Trades +12.2% vs the 50-day and +32.4% vs the 200-day average, 1.6% below the 52-week high and +74.4% off the 52-week low; a golden cross printed 30 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does IQVIA Holdings Inc do?

IQVIA supplies clinical trial services, commercial data and healthcare intelligence to life sciences and healthcare companies worldwide. It runs three segments: Technology & Analytics Solutions for cloud-based data and real-world evidence tools, Research & Development Solutions for running and supporting clinical trials and laboratory work, and Contract Sales & Medical Solutions for patient and provider engagement on behalf of clients. Its customers are pharmaceutical, biotechnology, device, diagnostic and consumer-health companies. The diary has not built a peer group for IQVIA. The name the market most often compares it with is ICON plc, another contract research organisation offering similar clinical-trial and laboratory services.

Where does IQVIA Holdings Inc sit in the AI build-out?

IQVIA holds no seat in Rubin, our index for the AI build-out. It sits in our universe's healthcare sleeve, under diagnostics and research, as a services and data provider that pharmaceutical and biotech companies use to run trials and read commercial markets. IQVIA carries no Closelook score and no Rubin seat. The only index tag the diary holds for it is a place in the S&P 500.

What has Wall Street done on IQVIA Holdings Inc recently?

The most recent analyst action on IQVIA Holdings Inc on the Closelook wire is a price target by Morgan Stanley on 2026-09-17 (target 270 from 240). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for IQV, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe